KND up +1.75% percent Today $KND High is at 20.87 and the

New Post Public Reply Private Reply Replies (0) Message Board

Nov 19, 2014 at 12:58 PM

KND up +1.75% percent Today $KND High is at 20.87 and the Low 20.05 with current volume of 502,493.

Recent News posted below.

Kindred Healthcare KND other info.
http://investorshangout.com/Kindred-Healthcare-KND-51609/

KND Kindred Healthcare Recent Headline News

Kindred Healthcare plans to issue concurrent public offerings of common stock & tangible equity units
M2 - Tue Nov 18, 5:50AM CST
Healthcare company Kindred Healthcare (NYSE:KND) on Monday launched concurrent underwritten public offerings of 5,000,000 shares of its common stock and 150,000 tangible equity units.
KND: 20.37 (+0.37)

Kindred Healthcare Earnings In Retrospect: Down 5.9% in the Last 12 Days (KND)
Comtex SmarTrend(R) - Mon Nov 17, 8:47AM CST
When Kindred Healthcare (NYSE:KND) reported earnings a week ago on November 5th, 2014, analysts, on average, expected the company to report earnings of $0.10 on sales of $1.3 billion. Kindred Healthcare actually reported earnings of $0.11 per share on sales of $1.2 billion, beating EPS estimates by $0.01 and missing revenue estimates by $7.3 million. Shares of Kindred Healthcare have slipped from $21.17 to $19.92, representing a loss of 5.9%, since the company reported earnings 12 days ago.
KND: 20.37 (+0.37)

Kindred Healthcare Announces Proposed Public Offerings Of Common Stock And Tangible Equity Units
PR Newswire - Mon Nov 17, 6:43AM CST
Kindred Healthcare, Inc. ("Kindred" or "the Company"

(NYSE:KND) today announced that it has launched concurrent underwritten public offerings of 5,000,000 shares of Kindred's common stock and 150,000 tangible equity units. Each tangible equity unit has a stated amount of $1,000 and is comprised of a prepaid stock purchase contract and a share of mandatory redeemable preferred stock, each issued by the Company. The Company intends to grant the underwriters a 13-day over-allotment option to purchase up to an additional 22,500 tangible equity units and a 30-day over-allotment option to purchase up to an additional 750,000 shares of Kindred's common stock. Citigroup Global Markets Inc. and J.P. Morgan Securities LLC are acting as the joint book-running managers for the concurrent offerings.
KND: 20.37 (+0.37), GTIV: 19.54 (+0.05)

3 Stocks With Upcoming Ex-Dividend Dates: GLV, BOI, KND
at The Street - Thu Nov 13, 9:04AM CST
GLV BOI KND are going ex-dividend tomorrow, Friday, November 14, 2014
KND: 20.37 (+0.37), BOI: 16.69 (-0.02), GLV: 14.52 (+0.11)

Kindred Announces Definitive Agreement to Acquire Centerre Healthcare
Business Wire - Wed Nov 12, 7:02AM CST
--Kindred to Establish New Growth Platform, Kindred Hospital Rehabilitation Services, Upon Closing of the Transaction
KND: 20.37 (+0.37), GTIV: 19.54 (+0.05)

Kindred Healthcare's (KND) CEO Paul Diaz on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Sat Nov 08, 12:40AM CST

KND: 20.37 (+0.37)

Kindred Healthcare's board approves USD0.12 per common share dividend
M2 - Fri Nov 07, 6:32AM CST
The board of directors of Kindred Healthcare (NYSE:KND), a US healthcare services company, on Thursday declared a quarterly dividend of USD0.12 per share of the company's common stock.
KND: 20.37 (+0.37)

Gentiva Earnings Miss Estimates, Up Y/Y; Outlook Reiterated - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 9:00AM CST
Gentiva Health Services, Inc. (GTIV) reported third-quarter 2014 adjusted earnings of 28 cents per share, missing the Zacks Consensus Estimate by a penny.
KND: 20.37 (+0.37), GTIV: 19.54 (+0.05), MOH: 50.04 (-0.73), WLP: 126.29 (-2.75)

Kindred Healthcare reports 3Q loss
Automated Insights - Thu Nov 06, 4:04AM CST
LOUISVILLE, Ky. (AP) _ Kindred Healthcare Inc. (KND) on Thursday reported a loss of $4.4 million in its third quarter.
KND: 20.37 (+0.37)

Kindred Healthcare beats by $0.01, revenue in-line
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 5:57PM CST

KND: 20.37 (+0.37)

Kindred Healthcare declares $0.12 dividend
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 5:45PM CST

KND: 20.37 (+0.37)

Kindred Healthcare Board of Directors Declares Quarterly Cash Dividend of $0.12 Per Share
Business Wire - Wed Nov 05, 5:35PM CST
Kindred Healthcare, Inc. ("Kindred" or the "Company"

(NYSE:KND) today announced that its Board of Directors approved the payment of the regular quarterly cash dividend to its shareholders. The quarterly cash dividend of $0.12 per common share will be paid on December 9, 2014 to shareholders of record as of the close of business on November 18, 2014. Future declarations of quarterly dividends will be subject to the approval of Kindred's Board of Directors.
KND: 20.37 (+0.37), GTIV: 19.54 (+0.05)

Kindred Healthcare Announces Third Quarter 2014 Results
Business Wire - Wed Nov 05, 5:30PM CST
--Solid Year Continues with 6% Growth in Consolidated Revenues and 7% Growth in Core Operating Income
KND: 20.37 (+0.37), GTIV: 19.54 (+0.05), VTR: 68.60 (-0.43)

Kindred Names David Causby as President-elect of Kindred at Home
Business Wire - Wed Nov 05, 4:45PM CST
Kindred Healthcare, Inc. ("Kindred" or the "Company"

(NYSE:KND) today announced that upon closing of the Company's previously announced acquisition of Gentiva Health Services, Inc. ("Gentiva"

(NASDAQ:GTIV), which is expected in the first quarter of 2015, David Causby will become the President of the combined Kindred at Home business.
KND: 20.37 (+0.37), GTIV: 19.54 (+0.05)

Kindred's Third Quarter Conference Call Scheduled for November 6
Business Wire - Tue Nov 04, 4:00PM CST
Kindred Healthcare, Inc. (the "Company"

(NYSE:KND) announced today that it will provide an online, real-time webcast of its conference call covering third quarter 2014 operating results and progress on the Company's previously announced definitive agreement to acquire Gentiva Health Services, Inc. (NASDAQ:GTIV) on Thursday, November 6, 2014. The Company will issue its third quarter 2014 earnings release after the close of trading on Wednesday, November 5, 2014.
KND: 20.37 (+0.37), GTIV: 19.54 (+0.05)

7 Old Dividend Dogs Of Healthcare Aim At 11% To 30.5% October Upsides
Fredrik Arnold - at Seeking Alpha - Mon Nov 03, 11:21AM CST

KND: 20.37 (+0.37), VIVO: 16.07 (-0.07), PETS: 13.38 (-0.12), PFE: 30.33 (-0.26), GSK: 46.40 (+0.12), MR: 30.95 (+0.19), SEM: 13.80 (-0.04), PDLI: 7.94 (-0.03), SNN: 34.10 (+0.32), AZN: 75.47 (+1.49), MRK: 59.50 (-0.39), STJ: 63.99 (-0.96), TRIB: 17.14 (-0.11), ABBV: 65.65 (-0.40), THRX: 13.62 (+0.27), SNY: 48.22 (-0.14)

Kindred Healthcare picks its president as next CEO
AP - Fri Oct 31, 9:57AM CDT
LOUISVILLE, Ky. (AP) — Kindred Healthcare picked its president and chief operating officer as its next CEO as the rehabilitation hospital operator's chief executive will step down in March.
KND: 20.37 (+0.37), GTIV: 19.54 (+0.05)

Kindred Names Benjamin A. Breier Chief Executive Officer-elect
Business Wire - Thu Oct 30, 3:30PM CDT
Kindred Healthcare, Inc. (the "Company" or "Kindred"

(NYSE:KND) today announced that Benjamin A. Breier will become Chief Executive Officer on March 31, 2015, succeeding Paul J. Diaz who will become Executive Vice Chairman of the Kindred Board of Directors. Mr. Breier will also become a member of Kindred's Board of Directors, effective March 31, 2015.
KND: 20.37 (+0.37), GTIV: 19.54 (+0.05)

INVESTOR ALERT: Levi & Korsinsky, LLP Launches Investigation of the Board of Directors of Gentiva Health Services Inc. Concerning the Fairness of the Sale of the Company to Kindred Healthcare Inc. -- GTIV
PR Newswire - Mon Oct 20, 10:35AM CDT
Levi & Korsinsky is investigating the Board of Directors of Gentiva Health Services Inc. ("Gentiva" or "the Company"

(NASDAQ: GTIV) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Kindred Healthcare Inc. (NYSE: KND).
KND: 20.37 (+0.37), GTIV: 19.54 (+0.05)

GENTIVA HEALTH SERVICES, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
Business Wire - Thu Oct 16, 9:55AM CDT
Rigrodsky & Long, P.A.:
KND: 20.37 (+0.37), GTIV: 19.54 (+0.05)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Uber Data Breach: Class Action Investigation Begins

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Manhattan Associates Faces Investigation by KSF Law Firm

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

MV Transportation Celebrates Leadership Nomination for FTA

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...

BETR's Slide: Investors Face Big Losses, Leadership Shift

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Novo's Research Unlocks New Insights into Food Noise

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

LaserAway Expands to 244 Clinics Over 20 Years

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Webull Faces Class Action: Key Details for Investors

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

CARsgen's CAR-T Breakthrough on China's Insurance List

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...